Abstract
Reflex syncope (synonym: neurally mediated [reflex] syncope) refers to a reflex response that, when triggered, gives rise to vaso-/venodilatation and/or bradycardia; however, the contribution of each of these two factors to systemic hypotension and cerebral hypoperfusion may differ considerably among affected individuals and may even differ in the same patient at different times. Since all forms of reflex syncope share essentially the same basic pathophysiology (i.e., they basically represent the same disorder as best as we currently understand), the apparent clinical differences only reflect primarily which specific trigger elicits the reflex.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brignole M, et al. Guidelines on management (diagnosis and treatment) of syncope: Update 2004. Europace. 2004;6:467–537.
Moya A, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–2671.
Del Rosso A, et al. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol. 2005;96:1431–1435.
Alboni P, et al. Clinical spectrum of neurally-mediated reflex syncopes. Europace. 2004;6: 55–62.
Alboni P, et al. Is vasovagal syncope a disease? Europace. 2007;9:83–87.
Brignole M, et al. A new management of syncope: Prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J. 2006;27:76–82.
Brignole M, et al. Prospective multicentre systematic guideline-based management of patients referred to the syncope units of general hospitals. Europace. 2010;12:109–118.
Alboni P, et al. An abnormal neural reflex plays a role in causing syncope in sinus bradycardia. J Am Coll Cardiol. 1993;22:1130–1134.
Brignole M, et al. Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1993;22:1123–1129.
Leitch JW, et al. Syncope associated with supraventricular tachycardia: An expression of tachycardia or vasomotor response. Circulation. 1992;85:1064–1071.
Benditt DG. Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation. Pacing Clin Electrophysiol. 1997;20:572–584.
Hamer AWF, Bray JE. Clinical recognition of neurally mediated syncope. Intern Med J. 2005;35:216–221.
Mathias CJ, et al. Observations on recurrent syncope and presyncope in 641 patients. Lancet. 2001;357:348–353.
Ganzeboom KS, et al. Prevalence and triggers of syncope in medical students. Am J Cardiol. 2003;91:1006–1008.
Benditt DG, et al. Effect of cough on heart rate and blood pressure in patients with “cough syncope”. Heart Rhythm. 2005;2:807–813.
Krediet CT, et al. Sharpey-Schafer was right: evidence for systemic vasodilatation as a mechanism of hypotension in cough syncope. Europace. 2008;10:486–488.
Omi W, et al. Swallow syncope, a case report and review of the literature. Cardiology. 2006;105:75–79.
Kapoor WN, et al. Defecation syncope. A symptom with multiple etiologies. Arch Intern Med. 1986;146:2377–2379.
Sakaguchi S, et al. Syncope associated with exercise, a manifestation of neurally mediated syncope. Am J Cardiol. 1995;75:476–481.
Colivicchi F, et al. Exercise-related syncope in young competitive athletes without evidence of structural heart disease: Clinical presentation and long-term outcome. Eur Heart J. 2002;23:1125–1130.
O‘Mara G, Lyons D. Postprandial hypotension. Clin Geriatr Med. 2002;18:307–321.
Puisieux F, et al. Intraindividual reproducibility of postprandial hypotension. Gerontology. 2002;48:315–320.
Sarzi Braga S, et al. Laughter-induced syncope. Lancet. 2005;366:426.
Krediet CTP, et al. Vasovagal syncope interrupting sleep?. Heart. 2004;90:e25.
Jardine DL, et al. Fainting in your sleep? Clin Auton Res. 2006;16:76–78.
Thomas JE. Hyperactive carotid sinus reflex and carotid sinus syncope. Mayo Clin Proc. 1969;44:127–139.
Puggioni E, et al. Results and complications of the carotid sinus massage performed according to the “Methods of Symptoms”. Am J Cardiol. 2002;89:599–601.
Brignole M, et al. Survival in symptomatic carotid sinus hypersensitivity. Am Heart J. 1992;123:687–692.
Livanis EG, et al. Situational syncope: response to head-up tilt testing and follow-up: comparison with vasovagal syncope. Pacing Clin Electrophysiol. 2004;27:918–923.
Menozzi C, et al. Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker. Am J Cardiol. 1993;72:1152–1155.
Maggi R, et al. Cardioinhibitory carotid sinus hypersensitivity predicts an asystolic mechanism of spontaneous neurally-mediated syncope. Europace. 2007;9:563–567.
Brignole M, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J. 2006;27:1085–1092.
Krediet P, et al. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation. 2002;106:1684–1689.
Brignole M, et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol. 2002;40:2054–2060.
van Dijk N, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol. 2006;48:1652–1657.
Croci F, et al. Efficacy and feasibility of isometric arm counter-pressure manoeuvres to abort impending vasovagal syncope during real life. Europace. 2004;6:287–291.
Reybrouck T, et al. Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol. 2002;25:1441–1446.
Foglia-Manzillo G, et al. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace. 2004;6:199–204.
Kinay O, et al. Tilt training for recurrent neurocardiogenic syncope: effectiveness, patient compliance, and scheduling the frequency of training sessions. Jpn Heart J. 2004;45:833–843.
On YK, et al. Is home orthostatic self-training effective in preventing neurocardiogenic syncope? A prospective and randomized study. Pacing Clin Electrophysiol. 2007;30:638–643.
Duygu H, et al. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: A prospective and randomized study. Pacing Clin Electrophysiol. 2008;31:592–596.
Flevari P, et al. Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients’ well-being. J Am Coll Cardiol. 2002;40:499–504.
Madrid AH, et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: A prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol. 2001;37:554–559.
Sheldon R, et al. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol. 1996;78:536–539.
Sheldon R, et al. Prevention of syncope trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation. 2006;113:1164–1170.
Brignole M, et al. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol. 1992;70:339–342.
Moya A, et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol. 1995;25:65–69.
Kaufman H, et al. Midodrine in neurally mediated syncope: a double-blind randomized cross-over study. Ann Neurol. 2002;52:342–345.
Raviele A, et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. Circulation. 1999;99:1452–1457.
Ward CR, et al. Midodrine: a role in the management of neurocardiogenic syncope. Heart. 1998;79:45–49.
Samniah N, et al. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol. 2001;88:80–83.
Perez-Lugones A, et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol. 2001;12: 935–938.
Salim MA, et al. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double blind, placebo-controlled, randomized trial. J Am Coll Cardiol. 2005;45:484–488.
di Girolamo E, et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1999;33:1227–1230.
Voss DM. Demand pacing and carotid sinus syncope. Am Heart J. 1970;79:544–547.
Morley CA, et al. Carotid sinus syncope treated by pacing. Analysis of persistent symptoms and role of atrio ventricular sequential pacing. Br Heart J. 1982;47:411–418.
Brignole M, et al. Long-term outcome of paced and non paced patients with severe carotid sinus syndrome. Am J Cardiol. 1992;69:1039–1043.
Claesson JE, et al. Less syncope and milder symptoms in patients treated with pacing for induced cardioinhibitory carotid sinus syndrome: a randomized study. Europace. 2007;9: 932–936.
Connolly SJ, et al. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 1999;33:16–20.
Sutton R, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. Circulation. 2000;102:294–299.
Ammirati F, et al. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation. 2001;104:52–57.
Connolly SJ, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): A randomized trial. JAMA. 2003;289:2224–2229.
Raviele A, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The Vasovagal Syncope and Pacing Trial (SYNPACE). Eur Heart J. 2004;25:1741–1748.
Sud S, et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med. 2007;120:54–62.
Sud S, et al. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope. Europace. 2007;9:312–318.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Brignole, M., Benditt, D.G. (2011). Reflex Syncope (Neurally Mediated Syncope). In: Syncope. Springer, London. https://doi.org/10.1007/978-0-85729-201-8_11
Download citation
DOI: https://doi.org/10.1007/978-0-85729-201-8_11
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-200-1
Online ISBN: 978-0-85729-201-8
eBook Packages: MedicineMedicine (R0)